The presence of p53 mutations in tumors is often associated with a worse prognosis, as these mutations can lead to more aggressive tumor behavior and resistance to conventional therapies. However, the specific impact of p53 mutations on prognosis can vary depending on the type of cancer and the nature of the mutation.
